Mitochondrial ribosomal protein L18 (MRPL18) is located on human chromosome 6q25.3. It is associated with large subunit of the mitochondrial ribosome and belongs to L18/eL5 protein family. The predicted structure of MRPL18 has RNA-binding domain with anti-parallel ß-sheet and a-helical bundle.
Synonyms: Anti-CES5A1; Anti-DAC; Anti-HSPC071; Anti-mitochondrial ribosomal protein L18
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: Mitochondrial ribosomal protein L18 (MRPL18) interacts with cytosolic 5S rRNA. MRPL18 is implicated in breast cancer.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC